Neoadjuvant or adjuvant chemotherapy in early breast cancer?
Author:
Affiliation:
1. Multidisciplinary Oncology Outpatient Clinic, Istituto di Candiolo, FPO-IRCCS, Candiolo, Italy
2. Department of Oncology, University of Torino, Torino, Italy
3. Division of Gynecological Surgery, Istituto di Candiolo, FPO-IRCCS, Candiolo, Italy
Funder
Associazione Italiana per la Ricerca sul Cancro
Ministero della Salute
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1746273
Reference65 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Molecular portraits of human breast tumours
3. Repeated observation of breast tumor subtypes in independent gene expression data sets
4. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
5. International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)
Cited by 81 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review;Journal of Drug Delivery Science and Technology;2024-10
2. Mass Spectrometry-Based Proteomics for Classification and Treatment Optimisation of Triple Negative Breast Cancer;Journal of Personalized Medicine;2024-09-05
3. Exploration of multi-layered nanofiber adjuvant implants of doxorubicin and resveratrol to prevent post-surgery tumor recurrence and invasion;Journal of Drug Delivery Science and Technology;2024-09
4. Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis;Cell Biology International;2024-08-20
5. Innovative Nanoscale Drug Delivery Strategies for Breast Carcinoma: A Comprehensive Exploration;Current Drug Metabolism;2024-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3